Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics

Journal of Proteome Research

Volumn 13, Issue 12, 2014, Pages 5956-5964

  Ahn, Seong Beom ^a   Mohamedali, Abidali ^b   Anand, Samyuktha ^b   Cheruku, Harish R ^a   Birch, Debra ^b   Sowmya, Gopichandran ^b   Cantor, David ^a   Ranganathan, Shoba ^b   Inglis, David W ^b   Frank, Ronald ^c   Agrez, Michael ^d   Nice, Edouard C ^e   Baker, Mark S ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d JOHN HUNTER HOSPITAL   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

colorectal cancer; functional proteomics; ovarian cancer; peptide array; proximity ligation assay; uPAR; v 6 integrin

Indexed keywords

ALPHA5 INTEGRIN; ALPHAVBETA6 INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; BETA6 INTEGRIN; HETERODIMER; INTEGRIN; UROKINASE; UROKINASE RECEPTOR; VITRONECTIN; TUMOR ANTIGEN;

ARTICLE; BINDING SITE; BIOASSAY; BIOINFORMATICS; CANCER CELL; COLON CANCER; COMPUTER MODEL; CONTROLLED STUDY; CRYSTAL STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; FUNCTIONAL PROTEOMICS; HT 29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARIAN CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROXIMITY LIGATION ASSAY; AMINO ACID SEQUENCE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEOMICS; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INTEGRINS; MOLECULAR SEQUENCE DATA; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEOMICS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84915747345     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500849x     Document Type: Article

References (54)

1. Nguyen, D. X.; Bos, P. D.; Massague, J. Metastasis: from dissemination to organ-specific colonization Nat. Rev. Cancer 2009, 9, 274-84
2. Kalluri, R.; Weinberg, R. A. The basics of epithelial-mesenchymal transition J. Clin. Invest. 2009, 119, 1420-8
3. Pepper, M. S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis Arterioscler., Thromb., Vasc. Biol. 2001, 21, 1104-17
4. Cox, G.; Steward, W. P.; O'Byrne, K. J. The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer Thorax 1999, 54, 169-79
5. Saldanha, R. G.; Molloy, M. P.; Bdeir, K.; Cines, D. B.; Song, X.; Uitto, P. M.; Weinreb, P. H.; Violette, S. M.; Baker, M. S. Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy J. Proteome Res. 2007, 6, 1016-28
6. Fagerberg, L.; Jonasson, K.; von Heijne, G.; Uhlen, M.; Berglund, L. Prediction of the human membrane proteome Proteomics 2010, 10, 1141-9
7. Smith, H. W.; Marshall, C. J. Regulation of cell signalling by uPAR Nat. Rev. Mol. Cell Biol. 2010, 11, 23-36
8. Llinas, P.; Le Du, M. H.; Gardsvoll, H.; Dano, K.; Ploug, M.; Gilquin, B.; Stura, E. A.; Menez, A. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide EMBO J. 2005, 24, 1655-63
9. Eden, G.; Archinti, M.; Furlan, F.; Murphy, R.; Degryse, B. The urokinase receptor interactome Curr. Pharm. Des. 2011, 17, 1874-89
10. Mekkawy, A. H.; Morris, D. L.; Pourgholami, M. H. Urokinase plasminogen activator system as a potential target for cancer therapy Future Oncol. 2009, 5, 1487-99
11. Seetoo, D. Q.; Crowe, P. J.; Russell, P. J.; Yang, J. L. Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer J. Surg. Oncol. 2003, 82, 184-93
12. Rabbani, S. A.; Mazar, A. P. The role of the plasminogen activation system in angiogenesis and metastasis Surg. Oncol. Clin. N. Am. 2001, 10, 393-415
13. Hynes, R. O. Integrins: versatility, modulation, and signaling in cell adhesion Cell 1992, 69, 11-25
14. Giancotti, F. G.; Ruoslahti, E. Integrin signaling Science 1999, 285, 1028-32
15. Liu, S.; Liang, B.; Gao, H.; Zhang, F.; Wang, B.; Dong, X.; Niu, J. Integrin alphavbeta6 as a novel marker for diagnosis and metastatic potential of thyroid carcinoma Head Neck Oncol. 2013, 5, 7
16. Bandyopadhyay, A.; Raghavan, S. Defining the role of integrin alphavbeta6 in cancer Curr. Drug Targets 2009, 10, 645-52
17. Bates, R. C. The alphaVbeta6 integrin as a novel molecular target for colorectal cancer Future Oncol. 2005, 1, 821-8
18. Annes, J. P.; Munger, J. S.; Rifkin, D. B. Making sense of latent TGFbeta activation J. Cell Sci. 2003, 116, 217-24
19. Gu, X.; Niu, J.; Dorahy, D. J.; Scott, R.; Agrez, M. V. Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells Br. J. Cancer 2002, 87, 348-51
20. Weinreb, P. H.; Simon, K. J.; Rayhorn, P.; Yang, W. J.; Leone, D. R.; Dolinski, B. M.; Pearse, B. R.; Yokota, Y.; Kawakatsu, H.; Atakilit, A.; Sheppard, D.; Violette, S. M. Function-blocking integrin alpha(v)beta(6) monoclonal antibodies-Distinct ligand-mimetic and nonligand-mimetic classes J. Biol. Chem. 2004, 279, 17875-17887
21. Tsao, S. W.; Mok, S. C.; Fey, E. G.; Fletcher, J. A.; Wan, T. S.; Chew, E. C.; Muto, M. G.; Knapp, R. C.; Berkowitz, R. S. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs) Exp. Cell Res. 1995, 218, 499-507
22. Agrez, M.; Chen, A.; Cone, R. I.; Pytela, R.; Sheppard, D. The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain J. Cell Biol. 1994, 127, 547-56
23. Weinacker, A.; Chen, A.; Agrez, M.; Cone, R. I.; Nishimura, S.; Wayner, E.; Pytela, R.; Sheppard, D. Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor J. Biol. Chem. 1994, 269, 6940-8
24. Frank, R. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports - principles and applications J. Immunol. methods 2002, 267, 13-26
25. Frank, R. Spot-Synthesis-an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support Tetrahedron 1992, 48, 9217-9232
26. Huai, Q.; Zhou, A.; Lin, L.; Mazar, A. P.; Parry, G. C.; Callahan, J.; Shaw, D. E.; Furie, B.; Furie, B. C.; Huang, M. Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes Nat. Struct. Mol. Biol. 2008, 15, 422-3
27. Abagyan, R.; Totrov, M.; Kuznetsov, D. ICM-A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation J. Comput. Chem. 1994, 15, 488-506
28. Li, Y.; Wood, N.; Yellowlees, D.; Donnelly, P. K. Cell surface expression of urokinase receptor in normal mammary epithelial cells and breast cancer cell lines Anticancer Res. 1999, 19, 1223-8
29. Ahmed, N.; Niu, J.; Dorahy, D. J.; Gu, X.; Andrews, S.; Meldrum, C. J.; Scott, R. J.; Baker, M. S.; Macreadie, I. G.; Agrez, M. V. Direct integrin alphavbeta6-ERK binding: implications for tumour growth Oncogene 2002, 21, 1370-80
30. Niu, J.; Gu, X.; Ahmed, N.; Andrews, S.; Turton, J.; Bates, R.; Agrez, M. The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression Int. J. Cancer 2001, 92, 40-8
31. Moreau, M.; Mourah, S.; Dosquet, C. beta-Catenin and NF-kappaB cooperate to regulate the uPA/uPAR system in cancer cells Int. J. Cancer 2011, 128, 1280-92
32. Ronne, E.; Behrendt, N.; Ploug, M.; Nielsen, H. J.; Wollisch, E.; Weidle, U.; Dano, K.; Hoyer-Hansen, G. Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay J. Immunol. Methods 1994, 167, 91-101
33. Persson, M.; Madsen, J.; Ostergaard, S.; Jensen, M. M.; Jorgensen, J. T.; Juhl, K.; Lehmann, C.; Ploug, M.; Kjaer, A. Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion J. Nucl. Med. 2012, 53, 138-45
34. Weibrecht, I.; Leuchowius, K. J.; Clausson, C. M.; Conze, T.; Jarvius, M.; Howell, W. M.; Kamali-Moghaddam, M.; Soderberg, O. Proximity ligation assays: a recent addition to the proteomics toolbox Expert Rev. Proteomics 2010, 7, 401-9
35. Thymiakou, E.; Episkopou, V. Detection of signaling effector-complexes downstream of bmp4 using PLA, a proximity ligation assay. J. Visualized Exp. 2011.
36. Breuss, J. M.; Gillett, N.; Lu, L.; Sheppard, D.; Pytela, R. Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues J. Histochem. Cytochem. 1993, 41, 1521-7
37. Li, S. S.; Wu, C. Using peptide array to identify binding motifs and interaction networks for modular domains Methods Mol. Biol. 2009, 570, 67-76
38. Maier, R. H.; Maier, C. J.; Rid, R.; Hintner, H.; Bauer, J. W.; Onder, K. Epitope mapping of antibodies using a cell array-based polypeptide library J. Biomol. Screening 2010, 15, 418-26
39. Barinka, C.; Parry, G.; Callahan, J.; Shaw, D. E.; Kuo, A.; Bdeir, K.; Cines, D. B.; Mazar, A.; Lubkowski, J. Structural basis of interaction between urokinase-type plasminogen activator and its receptor J. Mol. Biol. 2006, 363, 482-95
40. Chaurasia, P.; Aguirre-Ghiso, J. A.; Liang, O. D.; Gardsvoll, H.; Ploug, M.; Ossowski, L. A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth J. Biol. Chem. 2006, 281, 14852-63
41. Vassalli, J. D.; Baccino, D.; Belin, D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase J. Cell Biol. 1985, 100, 86-92
42. Blasi, F.; Carmeliet, P. uPAR: a versatile signalling orchestrator Nat. Rev. Mol. Cell Biol. 2002, 3, 932-43
43. Sowmya, G.; Khan, J. M.; Anand, S.; Ahn, S. B.; Baker, M. S.; Ranganathan, S. A site for direct integrin alphavbeta6.uPAR interaction from structural modelling and docking J. Struct. Biol. 2014, 185, 327-35
44. Hruby, V. J. Designing peptide receptor agonists and antagonists Nat. Rev. Drug Discovery 2002, 1, 847-58
45. Jo, M.; Eastman, B. M.; Webb, D. L.; Stoletov, K.; Klemke, R.; Gonias, S. L. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells Cancer Res. 2010, 70, 8948-58
46. Smith, H. W.; Marra, P.; Marshall, C. J. uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180 J. Cell Biol. 2008, 182, 777-90
47. Degryse, B.; Orlando, S.; Resnati, M.; Rabbani, S. A.; Blasi, F. Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways Oncogene 2001, 20, 2032-43
48. Bates, R. C. Colorectal cancer progression: integrin alphavbeta6 and the epithelial-mesenchymal transition (EMT) Cell Cycle 2005, 4, 1350-2
49. Ramos, D. M.; But, M.; Regezi, J.; Schmidt, B. L.; Atakilit, A.; Dang, D.; Ellis, D.; Jordan, R.; Li, X. Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma Matrix Biol. 2002, 21, 297-307
50. Li, X.; Yang, Y.; Hu, Y.; Dang, D.; Regezi, J.; Schmidt, B. L.; Atakilit, A.; Chen, B.; Ellis, D.; Ramos, D. M. Alphavbeta6-Fyn signaling promotes oral cancer progression J. Biol. Chem. 2003, 278, 41646-53
51. Ramos, D. M.; Dang, D.; Sadler, S. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer Anticancer Res. 2009, 29, 125-30
52. Morgan, M. R.; Thomas, G. J.; Russell, A.; Hart, I. R.; Marshall, J. F. The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9 J. Biol. Chem. 2004, 279, 26533-9
53. Xu, J.; Lamouille, S.; Derynck, R. TGF-beta-induced epithelial to mesenchymal transition Cell Res. 2009, 19, 156-72
54. Tang, X.; Bruce, J. E. A new cross-linking strategy: protein interaction reporter (PIR) technology for protein-protein interaction studies Mol. BioSyst. 2010, 6, 939-47